Global Health Repurposing Awards 2017 Blog Series

July 13, 2017

By Jennifer Ball

Tranfaglia GHRAIn 1992, Dr. Mike Tranfaglia’s son Andy was diagnosed with fragile X, a rare genetic disorder that causes mild to moderate intellectual disability. This diagnosis led Dr. Tranfaglia and his wife, Katie Clapp, to found FRAXA Research Foundation (, a nonprofit organization focusing on finding a cure for fragile X. As part of its research strategy, FRAXA has made a significant investment in repurposing research, which is why Cures Within Reach awarded FRAXA with the Golan Christie Taglia Patient Impact Philanthropy Award at the 2017 Global Health Repurposing Awards.

The mission of Cures Within Reach is to improve patient quality and length of life by leveraging the speed, safety, and cost-effectiveness of medical repurposing research to help drive treatments to patients. “This is a great honor for FRAXA, and great encouragement to us individually. We spend a lot of time working on a rare disease in relative obscurity, and so this recognition is important to us,” said Dr. Tranfaglia. Read full post!

Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*


If the link above doesn't work, please contact our Admin support at with your Full Name and Email Address to sign up!


Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Wednesday the 3rd. Copyright 2018 Cures Within Reach.